Dreamstime 78445850
Dreamstime 78445850
Dreamstime 78445850
Dreamstime 78445850
Dreamstime 78445850

eBook: Biopharma trends 2023

Aug. 28, 2023

The U.S. is the largest pharmaceutical market by value and its drug spending has continued to outgrow the global market — and this is largely driven by biologics, which have seen a compound annual growth rate of 12%. But as these new and innovative therapeutics race towards commercialization, the industry is grappling with the challenges of their highly complex and specific manufacturing processes.

This eBook will explore:

  • An in-depth look at the reappearing of antibody-drug conjugates
  • What it will take to make precision medicine a reality
  • How computational and AI advancements can help solve process design inefficiencies
  • How reducing technology-addressable vaccine barriers affects coverage rates
This content is sponsored by: Colbert Packaging


FDA approves Vertex-CRISPR gene-edited therapy for sickle cell

Dec. 11, 2023
The drug is the first CRISPR/Cas9 gene-edited therapy to be approved by the agency

eBook: 2023 Pharma Innovation Awards

Dec. 8, 2023
With drugmakers facing incredible pressures to get drugs to market quickly, safely and affordably, every addition to development and manufacturing efficiencies matters.

Editors' (re)View: Exploring cell therapy in autoimmune disease; AbbVie on the hunt

Dec. 8, 2023
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of December 4

Innovent Biologics, Synnafix expand ADC collaboration

Dec. 8, 2023
The new terms will grant Innovent access to additional targets